247 related articles for article (PubMed ID: 25544304)
1. Treatment of severe infantile hemangiomas with propranolol: an evaluation of the efficacy and effects of cardiovascular parameters in 25 consecutive patients.
Xu DP; Cao RY; Xue L; Sun NN; Tong S; Wang XK
J Oral Maxillofac Surg; 2015 Mar; 73(3):430-6. PubMed ID: 25544304
[TBL] [Abstract][Full Text] [Related]
2. Oral Propranolol for the Treatment of Infantile Hemangiomas in the Post-Proliferative Phase: A-Single Center Retrospective Study of 31 Cases.
Tian Y; Xu DP; Tong S; Xi SL; Liu ZM; Wang XK
J Oral Maxillofac Surg; 2016 Aug; 74(8):1623-9. PubMed ID: 27055227
[TBL] [Abstract][Full Text] [Related]
3. Large Doses of Propranolol for the Treatment of Infantile Cephalic and Facial Hemangiomas: A Clinical Report of 38 Cases.
Jianguo K; Xichun W; Mingkun Z; Qiaoling C; Wenjin L
J Clin Pediatr Dent; 2015; 39(3):268-71. PubMed ID: 26208073
[TBL] [Abstract][Full Text] [Related]
4. Oral Propranolol With Topical Timolol Maleate Therapy for Mixed Infantile Hemangiomas in Oral and Maxillofacial Regions.
Li G; Xu DP; Tong S; Xue L; Sun NN; Wang XK
J Craniofac Surg; 2016 Jan; 27(1):56-60. PubMed ID: 26716547
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular and blood glucose parameters in infants during propranolol initiation for treatment of symptomatic infantile hemangiomas.
Puttgen KB; Summerer B; Schneider J; Cohen BA; Boss EF; Bauman NM
Ann Otol Rhinol Laryngol; 2013 Sep; 122(9):550-4. PubMed ID: 24224397
[TBL] [Abstract][Full Text] [Related]
6. Topical timolol maleate for superficial infantile hemangiomas: an observational study.
Xu DP; Cao RY; Tong S; Xue L; Sun NN; Wang XK
J Oral Maxillofac Surg; 2015 Jun; 73(6):1089-94. PubMed ID: 25843815
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of infantile hemangiomas with low-dose propranolol: evaluation of short-term efficacy and safety].
Qin ZP; Liu XJ; Li KL; Zhou Q; Yang XJ; Zheng JW
Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(44):3130-4. PubMed ID: 20193276
[TBL] [Abstract][Full Text] [Related]
8. Twenty-four-hour hospitalization for patients initiating systemic propranolol therapy for infantile hemangiomas--is it indicated?
Liu LS; Sokoloff D; Antaya RJ
Pediatr Dermatol; 2013; 30(5):554-60. PubMed ID: 23829941
[TBL] [Abstract][Full Text] [Related]
9. The use of propranolol for complicated infantile hemangiomas.
Vercellino N; Romanini MV; Pelegrini M; Rimini A; Occella C; Dalmonte P
Int J Dermatol; 2013 Sep; 52(9):1140-6. PubMed ID: 23829783
[TBL] [Abstract][Full Text] [Related]
10. Propranolol and infantile hemangiomas: different routes of administration, a randomized clinical trial.
Zaher H; Rasheed H; Esmat S; Hegazy RA; Gawdat HI; Hegazy RA; El-Komy M; Abdelhalim DM
Eur J Dermatol; 2013; 23(5):646-52. PubMed ID: 24135427
[TBL] [Abstract][Full Text] [Related]
11. Failure of intralesional propranolol in infantile hemangiomas.
Torres-Pradilla M; Baselga E
Pediatr Dermatol; 2014; 31(2):156-8. PubMed ID: 24000875
[TBL] [Abstract][Full Text] [Related]
12. Oral propranolol for infantile hemangiomas: a prospective study on the role of 48-hour Holter monitoring in additional safety assessment.
Petrovic J; Trifunovic B; Vukomanovic G; Topalovic M; Trajkovic G; Parezanović V
J Dermatolog Treat; 2017 Sep; 28(6):554-558. PubMed ID: 28043186
[TBL] [Abstract][Full Text] [Related]
13. Safety and tolerance of propranolol in neonates with severe infantile hemangiomas: a prospective study.
Ji Y; Chen S; Xiang B; Yang Y; Qiu L
Sci Rep; 2017 May; 7(1):1503. PubMed ID: 28473717
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of superficial infantile hemangiomas with topical propranolol].
Niu JN; Xu GQ; Lü RR; Huo R
Zhonghua Zheng Xing Wai Ke Za Zhi; 2013 Mar; 29(2):100-3. PubMed ID: 23772486
[TBL] [Abstract][Full Text] [Related]
15. Clinical Outcomes of Infants With Periorbital Hemangiomas Treated With Oral Propranolol.
Xue L; Sun C; Xu DP; Liu ZM; Wang XK
J Oral Maxillofac Surg; 2016 Nov; 74(11):2193-2199. PubMed ID: 27235180
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of infantile parotid hemangioma with propranolol].
Liu XJ; Qin ZP; Tai MZ; Li KL; Ge CX
Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 May; 45(5):292-4. PubMed ID: 20654246
[TBL] [Abstract][Full Text] [Related]
17. Propranolol for problematic head and neck hemangiomas: an analysis of 37 consecutive patients.
Lv MM; Fan XD; Su LX
Int J Pediatr Otorhinolaryngol; 2012 Apr; 76(4):574-8. PubMed ID: 22326207
[TBL] [Abstract][Full Text] [Related]
18. [Propranolol in the treatment of problematic infantile hemangiomas].
Lu J; Qin G; Huang J; Li S; Zhao J; Xiang Y; Chen J; Zuo C; Yang S; Tna L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1102-5. PubMed ID: 22169728
[TBL] [Abstract][Full Text] [Related]
19. Use of propranolol for the treatment infantile hemangiomas in the maxillofacial region.
Sadykov RR; Podmelle F; Sadykov RA; Kasimova KR; Metellmann HR
Int J Oral Maxillofac Surg; 2013 Jul; 42(7):863-7. PubMed ID: 23618833
[TBL] [Abstract][Full Text] [Related]
20. Topical propranolol for treatment of superficial infantile hemangiomas.
Xu G; Lv R; Zhao Z; Huo R
J Am Acad Dermatol; 2012 Dec; 67(6):1210-3. PubMed ID: 22516113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
